Mucus-derived glycans are inhibitory signals for Salmonella Typhimurium SPI-1-mediated invasion

Kelsey M Wheeler1, Michaela A Gold2, Corey A Stevens1

  • 1Biological Engineering Department, Massachusetts Institute of Technology, Cambridge, MA, USA.

Cell Reports
|September 24, 2025
PubMed

Insights

Intestinal mucins inhibit Salmonella invasion by suppressing the HilD virulence regulator. Specific mucin sugars, N-acetyl galactosamine and N-acetyl glucosamine, mediate this anti-virulence effect, offering potential for new infection treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Glycobiology

Background:

  • Mucus acts as a barrier against enteric pathogens like Salmonella Typhimurium.
  • Core 3 glycosylation of mucins is protective, but mechanisms are unknown.

Purpose of the Study:

  • Elucidate the molecular mechanisms of mucin's protective effect against S. Typhimurium.
  • Identify specific mucin components responsible for anti-virulence activity.

Main Methods:

  • Investigated the effect of native intestinal mucins on Salmonella invasion of colonic epithelial cells.
  • Analyzed the role of mucin glycans and specific sugars in inhibiting the type 3 secretion system (T3SS) and HilD.
  • Examined the interaction between mucin sugars and HilD's putative carbohydrate-binding domain.

Main Results:

  • Native intestinal mucins inhibit Salmonella invasion by downregulating the T3SS.
  • Mucin glycans, specifically N-acetyl galactosamine and N-acetyl glucosamine, are responsible for the anti-virulence effect.
  • The native presentation of these sugars is crucial for their activity, likely through interaction with HilD.

Conclusions:

  • Mucins' anti-virulence effect is mediated by specific sugars that suppress the key virulence regulator HilD.
  • Mucin-based strategies show promise for combating enteric infections.
  • Mucins may act as broad-spectrum anti-virulence agents against pathogens with similar regulators.

Related Concept Videos